4//SEC Filing
Laponis Adam 4
Accession 0001214659-25-014856
CIK 0001581280other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:05 PM ET
Size
6.9 KB
Accession
0001214659-25-014856
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-08$31.15/sh−3,000$93,450→ 94,042 total - Sale
Common Stock
2025-10-09$32.92/sh−2,517$82,865→ 91,525 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001827198
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:05 PM ET
- Size
- 6.9 KB